The institute’s aim is to learn more about preventing heart disease using imaging techniques to improve diagnoses. The institute will employ a multidisciplinary team of physicians and scientists who will focus specifically on studying “vulnerable plaque”, a risk factor in heart attacks and sudden cardiac deaths, according to a news release.
In addition to using state-of-the-art imaging tools, the institute will also develop new technologies and diagnostic tests to advance its research.
James K. Min, MD, has been named director of the Dalio Institute. Dr. Min is currently an attending physician at NewYork-Presbyterian Hospital and a full-time faculty member of the Department of Radiology at New York City-based Weill Cornell Medical College. He is an expert in cardiovascular imaging and was previously the director of cardiac imaging research and co-director of imaging at Los Angeles-based Cedars-Sinai Medical Center.
More Articles on Hospital Expansion:
SCL Health System Plans 4 Community Hospitals in Colorado
Lexington Regional Health Center to Construct $2M Physicians Clinic
MaineGeneral Opens $312M Alfond Center for Health
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
